Evidence map›Paper›PMID 34443536›Full record

ArticleMolecules (Basel, Switzerland)2021

Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate.

Sang-Yun Lee, Yvonne Teng, Miseol Son, Bosung Ku, Hyun Ju Hwang, Vinay Tergaonkar, Pierce Kah-Hoe Chow, Dong Woo Lee, Do-Hyun Nam

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Biomedical applications of organoids derived from the digestive system.Frontiers in cell and developmental biology · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. The utilisation of biliary organoids for biomedical applications.Frontiers in bioengineering and biotechnology · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Sang-Yun LeeDepartment of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul 06351, Korea.
Yvonne TengResearch & Development Department, AVATAMED Pte. Ltd., Singapore 117408, Singapore.
Miseol SonResearch & Development Department, AVATAMED Pte. Ltd., Singapore 117408, Singapore.
Bosung KuCentral R & D Center, Medical & Bio Decision (MBD) Co., Ltd., Suwon 16229, Korea.
Hyun Ju HwangCentral R & D Center, Medical & Bio Decision (MBD) Co., Ltd., Suwon 16229, Korea.
Vinay TergaonkarLaboratory of NFκB Signaling, Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore 138673, Singapore.
Pierce Kah-Hoe ChowDivision of Surgery and Surgical Oncology, Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS), Singapore 169610, Singapore.
Dong Woo LeeCentral R & D Center, Medical & Bio Decision (MBD) Co., Ltd., Suwon 16229, Korea.
Do-Hyun NamDepartment of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul 06351, Korea.ORCID 0000-0002-8477-6791
Bio-Medical Science (South Korea) · KRSamsung (South Korea) · KRAgency for Science, Technology and Research · SGKonyang University · KRSingapore General Hospital · SG

Funding

A*STAR Industry Alignment Fund Pre-Positioning Fund (HBMS domain) H17/01/a/003the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) 202012E15-04the National Medical Research Council (NMRC) Clinician Scientist Award Senior Investigator (SI) Category NMRC/CSA-SI/0018/2017the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) 2020R1I1A3066550
6 · The paper itself

Abstract

A common method of three-dimensional (3D) cell cultures is embedding single cells in Matrigel. Separated cells in Matrigel migrate or grow to form spheroids but lack cell-to-cell interaction, which causes difficulty or delay in forming mature spheroids. To address this issue, we proposed a 3D aggregated spheroid model (ASM) to create large single spheroids by aggregating cells in Matrigel attached to the surface of 96-pillar plates. Before gelling the Matrigel, we placed the pillar inserts into blank wells where gravity allowed the cells to gather at the curved end. In a drug screening assay, the ASM with Hepatocellular carcinoma (HCC) cell lines showed higher drug resistance compared to both a conventional spheroid model (CSM) and a two-dimensional (2D) cell culture model. With protein expression, cytokine activation, and penetration analysis, the ASM showed higher expression of cancer markers associated with proliferation (p-AKT, p-Erk), tight junction formation (Fibronectin, ZO-1, Occludin), and epithelial cell identity (E-cadherin) in HCC cells. Furthermore, cytokine factors were increased, which were associated with immune cell recruitment/activation (MIF-3α), extracellular matrix regulation (TIMP-2), cancer interaction (IL-8, TGF-β2), and angiogenesis regulation (VEGF-A). Compared to CSM, the ASM also showed limited drug penetration in doxorubicin, which appears in tissues in vivo. Thus, the proposed ASM better recapitulated the tumor microenvironment and can provide for more instructive data during in vitro drug screening assays of tumor cells and improved prediction of efficacious drugs in HCC patients.

Indexed as

Imaging, Three-DimensionalModels, BiologicalAntineoplastic AgentsBiomarkers, TumorCarcinoma, HepatocellularCell AggregationCell Line, TumorCell ProliferationCytokinesDrug Resistance, NeoplasmDrug Screening Assays, AntitumorEpithelial CellsExtracellular MatrixFluorescenceHigh-Throughput Screening AssaysHumansAntineoplastic AgentsBiomarkers, TumorCytokinesTight Junction Proteins3D cell culture96-pillar/well platecancer spheroids in Matrigelhepatocellular carcinoma cell linehigh-throughput screeningin vitro extracellular matrix remodeling

Identifiers

PMID34443536
PMCPMC8399878
OpenAlexW3195240980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.